Attachment style predicts 6-month improvement in psychoticism in persons with at-risk mental states for psychosis

Early Intervention in Psychiatry
Yanet QuijadaNeus Barrantes-Vidal

Abstract

Insecure attachment may influence vulnerability to and outcome of psychotic symptomatology. The present study examined whether attachment style predicted symptoms and functioning of at-risk mental state (ARMS) patients after 6 months of psychosocial intervention, over and above the effects of initial clinical severity and premorbid social adjustment (PSA). Symptoms and functioning were assessed at baseline and 6 months later in 31 ARMS patients (mean age = 15.7). No patient received antipsychotic medication, but all engaged in intense psychosocial needs-adapted treatment. Clinicians (unaware of the aims of the study) rated attachment, PSA, symptoms, and functioning. Attachment was not related to baseline clinical severity. However, improvement in psychoticism was predicted by attachment (in particular by secure, preoccupied and dismissing) beyond the effects of baseline clinical severity and PSA. Secure attachment also predicted improvements in disorganization and functioning. Poor PSA predicted less improvement in disorganization and negative symptoms but did not impact psychoticism. The three attachment prototypes that predicted improvement in psychoticism (secure, preoccupied and dismissing) share the existence of at least o...Continue Reading

References

Aug 1, 1991·Journal of Personality and Social Psychology·K Bartholomew, L M Horowitz
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Apr 16, 1998·The British Journal of Psychiatry : the Journal of Mental Science·G Adshead
Jun 19, 1998·The British Journal of Clinical Psychology·H Close, P Garety
Mar 10, 2001·Psychological Medicine·P A GaretyP E Bebbington
Nov 16, 2001·Attachment & Human Development·M DozierS W Lee
Apr 2, 2002·Social Psychiatry and Psychiatric Epidemiology·Lydia KrabbendamJim van Os
Apr 13, 2002·Schizophrenia Research·Ashok K MallaJatinder Takhar
Aug 3, 2002·The American Journal of Psychiatry·Mark OlfsonMilton Fuentes
Nov 20, 2002·The British Journal of Clinical Psychology·Daniel FreemanPaul E Bebbington
Mar 4, 2003·The American Journal of Psychiatry·Jim van OsWilma Vollebergh
May 27, 2003·Schizophrenia Research·Katherine N ThompsonSusan M Harrigan
Mar 24, 2004·Schizophrenia Research·Gitry HeydebrandJohn G Csernansky
Jul 21, 2004·Current Psychiatry Reports·Diana O Perkins
Nov 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Lynda TaitPeter Trower
Mar 3, 2005·The American Journal of Psychiatry·Nancy C AndreasenDaniel R Weinberger
Sep 10, 2005·Schizophrenia Bulletin·Lydia Krabbendam, Jim van Os
Apr 28, 2006·Acta Psychiatrica Scandinavica·K A Olsen, B Rosenbaum
Apr 28, 2006·European Archives of Psychiatry and Clinical Neuroscience·Andreas BechdolfPatrick D McGorry
Jan 16, 2007·Clinical Psychology Review·Inez Myin-Germeys, Jim van Os
May 31, 2007·The American Journal of Orthopsychiatry·Alexander M PonizovskyPaula Rosca
Aug 19, 2007·The Journal of Nervous and Mental Disease·Shannon CoutureClaude Leclerc
Jul 1, 2008·European Psychiatry : the Journal of the Association of European Psychiatrists·Miguel Ruiz-VeguillaManuel Gurpegui
Aug 30, 2008·Nordic Journal of Psychiatry·J MäkinenH Koponen
Oct 18, 2008·Behaviour Research and Therapy·Katherine BerryAlison Wearden
Sep 18, 2010·Journal of Psychosomatic Research·Paula RavitzWilliam Lancee

❮ Previous
Next ❯

Citations

Nov 22, 2015·Schizophrenia Research·Kristina LyngbergJean Addington
Jul 10, 2013·Acta Psychiatrica Scandinavica·A I GumleyA MacBeth
Oct 9, 2015·BMC Psychiatry·Philippe HugueletPierre-Yves Brandt
Sep 7, 2016·Frontiers in Human Neuroscience·Martin DebbanéBenjamin K Brent
Apr 25, 2017·British Journal of Psychology·Debra A RussoJesus Perez
Nov 27, 2019·The Psychiatric Quarterly·Gustavo FrançaSerafim Carvalho
Nov 7, 2020·Harvard Review of Psychiatry·Daniel J DevoeJean Addington

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here